1. Bergh T., Nillius J. Prolactinomas. Follow-up of medical treatment. In: Molinatti G.M. (Ed.), A clinical problem: microprolactinoma. Diagnosis and treatment. Excerpta Medica, Amsterdam, 1982, p. 115.
2. Besser G.M., Wass J.A.H., Grossman A., Moult P.J.A., Bouloux P. Hormonal and clinical effects of dopamine agonists. In: Calne D.B. (Eds.), Lisuride and other dopamine agonists. Raven Press, New York, 1983, p. 239.
3. Liuzzi A., Chiodini P.G., Oppizzi G., Dallabonzana D., Spelta B., Silvestrini F., Rainer E., Horowski R. Medical treatment of pituitary adenomas: effects on hormonal secretion and tumor size. In: Calne D.B. (Eds.), Lisuride and other dopamine agonists. Raven Press, New York, 1983, p. 231.
4. Lee Vance M., Evans W.S., Thorner M.O. Bromocriptine. Ann. Intern. Med, 100: 78, 1984.
5. Von Werder K., Eversman T., Fahlbusch R., Müller O.A., Rijosk K. Endocrine-active pituitary adenomas: long-term results of medical and surgical treatment. In: Camanni F., Müller E.E. (Eds.), Pituitary hyperfunction: physiopathology and clinical aspects. Raven Press, New York, 1984, p. 385.